期刊名称：International Journal of Early Childhood Special Education
电子版ISSN：1308-5581
出版年度：2022
卷号：14
期号：5
页码：4483-4486
DOI：10.9756/INTJECSE/V14I5.532
语种：English
出版社：International Journal of Early Childhood Special Education
摘要：Liver disease has increased after the advent of highly active antiretroviral treatment, become a prominent non-AIDS-related cause of death in the HIV population. According to recent research, HIV Nonalcoholic fatty liver disease (NAFLD) is a type of liver disease that (NAFLD)and increasing liver fibrosis are more likely in individuals. The prevalence of the disease, its risk factors, and how to diagnose techniques for NAFLD in HIV mono-infected patients are summarized below.Non-AIDS causes of morbidity and mortality are becoming more common in HIV patients who have been infected for a long time. Liver disorders, in particular, have risen to one of the leading causes of death not connected to AIDS. When evaluating and caring for these patients, a complete understanding of the mechanisms underlying the development of liver disease is critical. Patient information: A patient is a 31year old male, having chief complaints is hiccups, giddiness,hematemesis Malena, yellow discoloration of the skin, and also having fatigue and weakness. His weightis 46kg. He is admitted to the hospital on the date 10-12-2021. Clinical findings: The patient appeared awake and oriented with individuals on general inspection. There are no high-risk variables. He was pale, anxious, and dyspnoeic throughout the examination. Patients with clinical symptoms that are very similar to those of our case have lately been described. Hehas circulating antibodies. Medical Management: Inhibitor drug-like inj. Cefotaxime 1 mg,antibiotic, tab. Zifi cv 200 mg,and inj. Metro 100 ml, and inhibiter also inj. Pan 40 mg, antiemetic that is inj. Emset 4mg. Prescribed. These drugs suppress the immune system and also provide inj. Vitamin k 10 mg. Nursing Management: Administered fluid replacement (DNS and RL), maintained intake and output charts, and hourly monitored all vital signs. Conclusion: Development of antibodies against the HIV and liver cirrhosis; after providing medication, patients health was improved.
